共 50 条
- [1] Clinical Characteristics and Healthcare Resource Utilization for Patients With Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review [J]. JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (01): : 117 - 127
- [5] Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review [J]. JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (02): : 67 - 76
- [10] Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series [J]. Orphanet Journal of Rare Diseases, 11